Huizhou Xingfuzhan Family Planning Supplies Trading Co., Ltd. – Trademark Portfolio
Entity Type: 99
Huizhou Xingfuzhan Family Planning Supplies Trading Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include LOVEVITA. The owner is based in Huizhou, Guangdong.
Sandong Town, Huicheng Dist
No. 314, Area D, Dajingkou Vil,Muli
Huizhou, Guangdong 516000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Huizhou Xingfuzhan Family Planning Supplies Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does Huizhou Xingfuzhan Family Planning Supplies Trading Co., Ltd. have?
Huizhou Xingfuzhan Family Planning Supplies Trading Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Huizhou Xingfuzhan Family Planning Supplies Trading Co., Ltd. file in?
Huizhou Xingfuzhan Family Planning Supplies Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Huizhou Xingfuzhan Family Planning Supplies Trading Co., Ltd.'s most well-known trademarks?
Huizhou Xingfuzhan Family Planning Supplies Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as LOVEVITA. These are among 1 currently registered trademark in the portfolio.
What is Huizhou Xingfuzhan Family Planning Supplies Trading Co., Ltd.'s trademark registration success rate?
Huizhou Xingfuzhan Family Planning Supplies Trading Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.